Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 6/20 | 0.54 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.37 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.37 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3073117 | 0.69 | ALDH1A1 (0.60) | ALDH1A1MAPTTP53SMN1; SMN2HPGD | |
| SCHEMBL3075030 | 0.69 | MAPT (0.56) | ALDH1A1MAPTTP53SMN1; SMN2LMNA | |
| SCHEMBL9794796 | 0.68 | L3MBTL1 (0.46) | ALDH1A1TP53SMN1; SMN2HPGDLMNA | |
| SCHEMBL3549560 | 0.68 | RAB9A (0.61) | ALDH1A1MAPTTP53SMN1; SMN2TSHR | |
| SCHEMBL3086401 | 0.68 | MAPT (0.66) | ALDH1A1MAPTTP53HPGDLMNA | |
| SCHEMBL14266195 | 0.66 | ALDH1A1 (0.52) | ALDH1A1MAPTTP53SMN1; SMN2HPGD | |
| SCHEMBL3075675 | 0.64 | NPC1 (0.60) | ALDH1A1MAPTTP53SMN1; SMN2HPGD | |
| SCHEMBL3552178 | 0.64 | NPC1 (0.77) | ALDH1A1MAPTSMN1; SMN2POLBRAB9A | |
| SCHEMBL28339173 | 0.63 | ALDH1A1 (0.53) | ALDH1A1MAPTTP53SMN1; SMN2HPGD | |
| SCHEMBL3120227 | 0.63 | NOS3 (0.38) | ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100261708-A1 | Diazepane Compounds Which Modulate The CB2 Receptor | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261708-A1 | Diazepane Compounds Which Modulate The CB2 Receptor | CNR1, CNR2, BDKRB2 | ALDH1A1 2369/4885MAPT 3696/4885TP53 4870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.